CYP1A2*1F polymorphism decreases clinical response to clozapine in patients with schizophrenia
Introduction: Genetic polymorphisms of cytochrome P450 (CYP) may predict the treatment response or occurrence of side effects of antipsychotic drugs. Aim: We studied the association of response to clozapine treatment in schizophrenic patients in relation to polymorphisms in the CYP1A2 gene. Met...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Mesut Çetin
2021-02-01
|
| Sraith: | Psychiatry and Clinical Psychopharmacology |
| Ábhair: | |
| Rochtain ar líne: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/2368 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|